We've found
10,154
archived clinical trials in
Other Indications
We've found
10,154
archived clinical trials in
Other Indications
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Updated: 1/23/2013
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Click here to add this to my saved trials
A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
Updated: 1/25/2013
Pilot Study of the Clinical Activity of Eculizumab for Prevention of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 1/25/2013
A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
Updated: 1/25/2013
Pilot Study of the Clinical Activity of Eculizumab for Prevention of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Updated: 1/25/2013
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Click here to add this to my saved trials
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Updated: 1/31/2013
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Click here to add this to my saved trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Updated: 2/18/2013
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Updated: 2/18/2013
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
Click here to add this to my saved trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Updated: 2/18/2013
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Updated: 2/18/2013
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
Click here to add this to my saved trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Updated: 2/18/2013
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Updated: 2/18/2013
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
Click here to add this to my saved trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Updated: 2/18/2013
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Updated: 2/18/2013
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
Click here to add this to my saved trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Updated: 2/18/2013
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Updated: 2/18/2013
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
Click here to add this to my saved trials
Nutrition, Exercise, and Breast Cancer Survivorship
Updated: 2/21/2013
Impact of Nutrition and Exercise on Glucose Metabolism, Inflammation, and Body Composition in Older Breast Cancer Survivors
Status: Enrolling
Updated: 2/21/2013
Nutrition, Exercise, and Breast Cancer Survivorship
Updated: 2/21/2013
Impact of Nutrition and Exercise on Glucose Metabolism, Inflammation, and Body Composition in Older Breast Cancer Survivors
Status: Enrolling
Updated: 2/21/2013
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
Updated: 2/22/2013
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Updated: 2/28/2013
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated: 2/28/2013
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Updated: 2/28/2013
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated: 2/28/2013
Click here to add this to my saved trials
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Updated: 2/28/2013
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated: 2/28/2013
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Updated: 2/28/2013
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated: 2/28/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials